全球药用明胶市场规模（按类型、应用、来源、最终用户、区域范围和预测）

药用明胶市场规模及预测

预计 2024 年药用明胶市场价值将达到 12.4 亿美元，2031 年将达到 17.9 亿美元，2024 年至 2031 年的复合年增长率为 5.20%。

药用明胶来自动物皮肤、白色结缔组织和骨骼中的胶原蛋白部分水解，具有分子量大、热可逆性、生物相容性和水溶性好等特点，是製药工业中重要的辅料。

明胶主要用于製造硬胶囊和软胶囊，作为屏障保护鱼油等敏感成分免受氧气、光、污染和微生物生长的影响。

它的用途包括片剂粘合剂、疫苗稳定剂以及製药业的其他重要用途。

约 90% 的药用明胶用于製造常用的处方剂型，如软胶囊、硬胶囊和片剂。

製药业高度依赖明胶来提高药物的稳定性、功效和生物有效性。药用明胶有助于包覆和保护活性药物成分，并在膜衣锭和发泡的研发中发挥关键作用。

明胶的生产涉及胶原蛋白的水解，该过程经过严格控制，以确保最终产品符合严格的药品级标准。

全球药用明胶市场动态

影响全球药用明胶市场的关键市场动态是：

关键市场驱动因素

生物医学和化妆品：明胶越来越多地用于生物医学和化妆品应用，包括创伤治疗、伤口敷料、组织工程、基因治疗、骨骼替代品、植入等。明胶的多种特性使其成为一种有价值的成分，在这些领域提供必不可少的功能，例如组织再生和药物输送。

药用级明胶需求不断增长：药用级明胶需求的不断增长也是市场的主要驱动力。需求的增长归因于糖尿病、癌症和心血管疾病等慢性疾病的日益流行，这些疾病需要持续用药和复杂的药物配方。药用明胶在这些製剂中至关重要，尤其是缓释性胶囊和软胶囊，它们比传统药片具有更高的生物利用度，也更容易吞嚥。由于软胶囊的消费者友善特性，人们开始转向软胶囊，这进一步推动了药用明胶的需求。

再生医学：明胶製造技术的进步使生产过程更有效率、更具成本效益，从而支持了市场的成长。随着再生医学和组织工程领域的不断发展，明胶在治疗应用方面的需求也越来越大，这也成为成长的催化剂。明胶在这些领域的关键作用凸显了其在製药业的重要性。

鱼明胶在免疫学中的应用：鱼明胶的应用也越来越受欢迎，因为它比传统来源的明胶有许多优点。鱼明胶具有免疫安全性，可降低传播牛脑病变和口蹄疫等疾病的风险，并具有环境和经济效益。这些因素促使人们对鱼明胶的偏好日益增长，并提升了其在医药领域的市场份额。

强化软糖的流行：强化软糖作为维生素和矿物质的替代输送系统，其需求激增也推动了药用明胶市场的成长。明胶的天然来源、生物相容性、热可逆性和洁净标示适用性等特性使其成为这些应用的理想选择。

主要挑战

替代成分的存在：对羟丙基甲基纤维素 (HPMC) 和改性淀粉等植物来源替代品的需求日益增长，正在对製药业产生影响。这些替代成分越来越多地被用于生产素食和纯素胶囊壳。素食和植物来源产品的日益增长趋势给动物基明胶市场带来了挑战，并可能导致其需求下降。

对动物性明胶的担忧：药用明胶主要来自动物产品，例如牛和猪皮及骨。围绕着动物性成分使用的文化、宗教和伦理担忧，已导致消费者和监管机构的审查力度加大。这些担忧促使人们寻找明胶的替代来源和替代品，这可能会限制市场成长。

替代品的可用性：替代辅料和药物成分（包括植物来源或合成聚合物）的出现，对药用明胶市场构成了挑战。製造商可能会选择这些替代品来满足消费者对素食或纯素产品的偏好，或解决对动物性成分的担忧。这些变化可能会影响传统药用明胶的需求。

原料价格波动：明胶生产中使用的原料（例如兽皮、骨骼和毛皮）价格波动剧烈。受供需动态、影响牲畜的环境因素以及地缘政治问题的影响，这些价格波动可能会影响生产成本和利润率。此类价格波动可能给药明胶市场带来挑战。

过敏原问题：明胶过敏虽然罕见，但敏感族群也可能出现明胶过敏，导致对含明胶药物产生不良反应。此类过敏原问题可能会影响消费者的选择，尤其是已知过敏或寻求替代剂型的消费者。此类问题可能会限制某些患者族群对明胶药物的接受度。

主要趋势

新兴市场扩张：亚太、中东、拉丁美洲和非洲等新兴地区为药用明胶市场带来了巨大的机会。为了满足日益增长的药用明胶需求，各公司越来越关注这些地区。例如，领先的製造商正在印度和中国等国家扩大业务和产能。这一趋势的驱动力在于这些经济体对明胶日益增长的需求、原材料供应充足以及低廉的人事费用，这些因素共同为市场带来了巨大的成长前景。

创新应用与技术：技术进步正在推动明胶在製药业的创新应用蓬勃发展。 etectRx, Inc. 开发的 ID-Cap 系统就是一个显着的例子，该系统将硬明胶胶囊与可吞嚥的无线感测器和可穿戴读取器整合在一起，用于监测服药依从性。此类技术创新正在扩大明胶在智慧胶囊等先进应用中的使用，而智慧胶囊预计将透过增强明胶基产品的功能性和吸引力来推动市场成长。

聚焦明胶表征：分析技术的进步正在改进明胶表征方法，提高产品品质和一致性。这些进步使我们能够更精确地控制明胶的物理和化学特性，确保其符合严格的製药应用要求。改进的表征方法有助于开发高品质的明胶产品，这对于有效的药物传输和製剂至关重要。

改性明胶的开发：研究人员正在积极开发具有特定性能的改性明胶，用于标靶药物递送和其他特殊药物应用。这些改质明胶旨在满足特定的性能标准，例如控制释放或提高稳定性，从而显着提高药物製剂的有效性，并拓展明胶在製药业的应用范围。

探索植物来源替代品：虽然动物基明胶仍占据市场主导地位，但人们对植物来源替代品的兴趣日益浓厚。此类替代品的开发是为了满足饮食偏好和宗教限制，这些限制不允许使用动物产品。消费者对纯素食和素食产品的需求日益增长，推动了植物来源胶替代品的探索，旨在提供符合伦理和文化考虑的解决方案。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概况
• 市集亮点

第三章 市场概况

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

4. 药用明胶市场类型

• A型明胶
• B型明胶

5. 药用明胶市场的应用

• 胶囊和软胶囊
• 被覆剂
• 肠外製剂
• 其他用途

6. 药用明胶市场（依来源）

• 牛明胶
• 猪肉明胶
• 其他来源

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市占率分析

第十章：公司简介

• Nitta Gelatin
• PB Leiner GmbH
• Tessenderlo Group
• Weishardt Holding GmbH & Co. KG
• Gelita AG
• LAPI Gelatine SpA
• NiOx Gelatin
• Croda International Plc
• Eastman Chemical Company
• Rousselot（ADM）
• I gelatina SA
• Gelnex Pharmaceuticals
• Bio-Gelatin GmbH
• Gelatin Kelco Co.

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

Pharmaceutical Gelatin Market Size And Forecast

Pharmaceutical Gelatin Market size was valued at USD 1.24 Billion in 2024 and is projected to reach USD 1.79 Billion by 2031, growing at a CAGR of 5.20% from 2024 to 2031.

Pharmaceutical gelatin, derived fr.om the partial hydrolysis of collagen obtained from animal skin, white connective tissues, and bones, is characterized by its high molecular weight, thermo-reversibility, biocompatibility, and water solubility. These properties make it a crucial excipient in the pharmaceutical industry.

Gelatin is predominantly used in the manufacture of hard capsules and soft gels, serving as a protective barrier that shields sensitive ingredients, such as fish oil, from oxygen, light, contamination, and microbiological growth.

Its applications extend to binding agents in tablet formulations, stabilizers in vaccines, and other vital uses in pharmaceutical products.

Approximately 90% of gelatin produced for pharmaceutical purposes is utilized in creating commonly prescribed dose forms, including softgels, hard capsules, and tablets.

The pharmaceutical industry relies heavily on gelatin due to its ability to enhance drug stability, effectiveness, and bioavailability. Pharmaceutical gelatin helps encapsulate and protect active pharmaceutical ingredients and plays a critical role in developing film-coated and effervescent tablets.

The production of gelatin involves the hydrolysis of collagen, which is carefully controlled to ensure the final product meets stringent pharma-medical grade standards.

Global Pharmaceutical Gelatin Market Dynamics

The key market dynamics that are shaping the global pharmaceutical gelatin market include:

Key Market Drivers

Biomedical and Cosmetic: The growing use of gelatin in biomedical and cosmetic applications, including wound healing, wound dressing, tissue engineering, gene therapy, bone substitutes, and implants. Gelatin's versatile properties make it a valuable component in these areas, providing essential functions such as tissue regeneration and drug delivery.

Increasing Demand for Pharmaceutical Grade: The rising demand for pharmaceutical-grade gelatin is also a significant market driver. This increase is attributed to the escalating prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions, which require ongoing medication and sophisticated drug formulations. Pharmaceutical gelatin is crucial in these formulations, particularly in sustained-release and soft gel capsules, which offer better bioavailability and are easier to swallow compared to traditional tablets. The shift towards soft gel capsules, driven by their consumer-friendly characteristics, is further fueling the demand for pharmaceutical gelatin.

Regenerative Medicine: The advancements in gelatin manufacturing technologies are enhancing the efficiency and cost-effectiveness of production processes, thereby supporting market growth. The increasing application of gelatin in regenerative medicine and tissue engineering is another growth catalyst, as these fields expand and demand more advanced materials for therapeutic applications. Gelatin's role as a key component in these areas highlights its importance in the pharmaceutical industry.

Fish Gelatin in Immunological: The use of fish-derived gelatin is also gaining traction, offering several advantages over traditional sources. Fish gelatin is immunologically safe, reduces the risk of transmitting diseases such as bovine spongiform encephalopathy and foot-and-mouth disease, and provides environmental and economic benefits. These factors contribute to the growing preference for fish gelatin, driving its market share within the pharmaceutical sector.

Popularity for Fortified Gummies: The surge in demand for fortified gummies, which serve as alternative delivery systems for vitamins and minerals, is also contributing to the growth of the pharmaceutical gelatin market. Gelatin's properties, such as its natural origin, biocompatibility, thermo-reversibility, and clean label-friendly characteristics, make it an ideal choice for these applications.

Key Challenges:

Presence of Substitute Components: The rising demand for plant-based alternatives, such as hydroxypropyl methylcellulose (HPMC) and modified starch, is influencing the pharmaceutical industry. These substitutes are increasingly used to produce vegetarian and vegan capsule shells. As the trend toward veganism and plant-based products grows, it poses a challenge to the market for animal-derived gelatin, potentially reducing its demand.

Concerns Regarding Animal-Derived Gelatin: Pharmaceutical gelatin is primarily sourced from animal by-products, such as bovine or porcine skin and bones. Cultural, religious, and ethical concerns surrounding the use of animal-derived ingredients are leading to increased scrutiny from consumers and regulatory bodies. These concerns are driving the search for alternative sources and substitutes for gelatin, which could limit market growth.

Availability of Alternatives: The availability of alternative excipients and formulation ingredients, including plant-based or synthetic polymers, presents a challenge to the pharmaceutical gelatin market. Manufacturers may opt for these alternatives to meet consumer preferences for vegetarian or vegan products or to address concerns related to animal-derived ingredients. This shift could impact the demand for traditional pharmaceutical gelatin.

Price Volatility of Raw Materials: The cost of raw materials used in gelatin production, such as animal hides, bones, and skins, can be volatile. Fluctuations in these prices, driven by supply and demand dynamics, environmental factors affecting livestock, and geopolitical issues, can affect production costs and profit margins. This price instability may pose a challenge to the pharmaceutical gelatin market.

Allergen Concerns: Although rare, gelatin allergies can occur in sensitive individuals, leading to adverse reactions from gelatin-containing pharmaceutical products. These allergen concerns can influence consumer choices, particularly among those with known allergies or those seeking alternative dosage forms. Such concerns could limit the adoption of pharmaceutical gelatin in certain patient populations.

Key Trends

Expansion in Emerging Markets: Emerging regions such as Asia-Pacific, the Middle East, Latin America, and Africa present substantial opportunities for the pharmaceutical gelatin market. Companies are increasingly focusing on these areas to tap into the growing demand for pharmaceutical-grade gelatin. For instance, major manufacturers are expanding their presence and production capabilities in countries like India and China. This trend is driven by the rising demand for gelatin in these economies, the availability of raw materials, and lower labor costs, which collectively provide significant growth prospects for the market.

Innovative Applications and Technologies: The pharmaceutical industry is witnessing a surge in innovative applications of gelatin, driven by advancements in technology. A notable example is etectRx, Inc.'s development of the ID-Cap System. This system integrates a hard gelatin capsule with an embedded ingestible wireless sensor and a wearable reader to monitor drug adherence. Such innovations are expanding the use of gelatin in advanced applications, such as smart capsules, and are likely to drive market growth by enhancing the functionality and appeal of gelatin-based products.

Focus on Gelatin Characterization: Advances in analytical techniques are improving the characterization of gelatin, leading to enhanced product quality and consistency. These advancements enable more precise control over gelatin's physical and chemical properties, ensuring that it meets the stringent requirements of pharmaceutical applications. Improved characterization supports the development of high-quality gelatin products that are critical for effective drug delivery and formulation.

Development of Modified Gelatins: Researchers are actively developing modified gelatins with specific properties tailored for targeted drug delivery and other specialized pharmaceutical applications. These modified gelatins are designed to meet specific performance criteria, such as controlled release or enhanced stability, which can significantly improve the efficacy of drug formulations and expand the range of applications for gelatin in the pharmaceutical industry.

Exploration of Plant-Based Alternatives: Although animal-derived gelatin remains dominant in the market, there is growing interest in plant-based alternatives. These alternatives are being developed to cater to dietary preferences and religious restrictions that preclude the use of animal-based products. The exploration of plant-based gelatin substitutes is driven by increasing consumer demand for vegan and vegetarian products and aims to provide solutions that align with ethical and cultural considerations.

Global Pharmaceutical Gelatin Market Regional Analysis

Here is a more detailed regional analysis of the global pharmaceutical gelatin market:

North America

North America substantially dominates the global pharmaceutical gelatin market and is expected to maintain its dominance throughout the forecast period driven by a combination of well-established pharmaceutical industries, robust research and development (R&D) activities, and a growing demand for pharmaceutical products.

As the largest market for pharmaceutical gelatin in North America, the United States benefits from a mature pharmaceutical industry and significant investments in R&D. The country's market growth is supported by the presence of leading gelatin manufacturers, increasing demand for nutraceuticals, and substantial funding for innovation in drug delivery systems.

The U.S. pharmaceutical sector's advanced infrastructure and high standards for product quality further drive the demand for pharmaceutical-grade gelatin, contributing to its dominance in the market.

Canada also holds a significant share of the North American pharmaceutical gelatin market. The growth in Canada is driven by an aging population, a rising prevalence of chronic diseases, and a growing need for advanced drug delivery solutions.

North America's stringent regulatory framework and high-quality standards have created a strong demand for pharmaceutical gelatin products. The region's focus on maintaining rigorous quality control and ensuring compliance with health regulations enhances the credibility and safety of pharmaceutical products.

The North American region's commitment to improving healthcare infrastructure and investing in pharmaceutical research supports the expansion of the pharmaceutical gelatin market.

Asia Pacific

The Asia-Pacific region is poised fastest growth in the global pharmaceutical gelatin market, driven by a convergence of factors that are creating a favorable environment for expansion.

The region's burgeoning pharmaceutical industry is a key driver, with both domestic and multinational companies making significant investments in research and development, manufacturing, and distribution. This growth is complemented by the easy availability of gelatin sources, which supports the increasing demand for this critical excipient.

The region's rising population and increasing life expectancy. The growing and aging demographic is leading to a higher demand for healthcare services and medications, which in turn fuels the need for pharmaceutical gelatin.

The region's robust pharmaceutical sector is fostering a dynamic market environment, where the demand for high-quality gelatin is rising in tandem with the industry's expansion.

Additionally, the increasing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer is contributing to the growing need for pharmaceutical products. Gelatin plays a crucial role in the formulation of various medications and supplements that address these chronic health issues.

As more individuals move into higher income brackets, there is a corresponding rise in healthcare expenditure, including spending on advanced pharmaceutical products that often incorporate gelatin.

Furthermore, favorable government initiatives are playing a significant role in supporting the pharmaceutical industry across the region. Many countries are implementing policies designed to boost the pharmaceutical sector, creating an advantageous environment for gelatin manufacturers.

Global Pharmaceutical Gelatin Market: Segmentation Analysis

The Global Pharmaceutical Gelatin Market is segmented based on Type, Application, Source, End-Use, And Geography.

Pharmaceutical Gelatin Market, By Type

Type A Gelatin

Type B Gelatin

Based on Type, the Global Pharmaceutical Gelatin Market is bifurcated into Type A Gelatin and Type B Gelatin. The Type B Gelatin segment dominates the global pharmaceutical gelatin market owing to the cost-effective production associated with the availability of raw materials, which helps to keep manufacturing costs down. Type B gelatin, in particular, offers increased gel storage stability compared to low-bloom gelatin, making it a preferred choice among industry players. This enhanced stability ensures that the soft gels maintain their quality and effectiveness over time, further bolstering the segment's growth and prominence in the market.

Pharmaceutical Gelatin Market, By Application

Hard Capsules

Softgel Capsules

Coatings

Parenteral Formulations

Based on Application, the Global Pharmaceutical Gelatin Market is bifurcated into Hard Capsules, and Softgel Capsules. The Soft Gel Capsules segment leads the Global Pharmaceutical Gelatin Market. Soft gel capsules are ideal for low-dose, lipid-soluble medications, offering uniform content distribution that enhances effectiveness and reliability. Their superior bioavailability improves the absorption of active ingredients, making them a preferred choice for various pharmaceutical applications.

Pharmaceutical Gelatin Market, By Source

Bovine Gelatin

Porcine Gelatin

Chicken Gelatin

Marine Gelatin

Based on the Source, the Global Pharmaceutical Gelatin Market is bifurcated into Bovine Gelatin, Porcine Gelatin, Chicken Gelatin, and Marine Gelatin. Porcine gelatin dominates the global pharmaceutical gelatin market. Its quick manufacturing cycle and cost-effective production processes contribute to its widespread use in the industry. Additionally, porcine-based gelatin is utilized in a variety of pharmaceutical applications, including as a stabilizer in vaccines and capsules. According to the National Health Service (NHS), porcine-derived gelatin plays a crucial role in maintaining the efficacy and safety of these products, especially during and after storage. These benefits drive the strong market share of porcine-sourced gelatin, making it a preferred choice for pharmaceutical formulations.

Pharmaceutical Gelatin Market, By End-User

Protein Bars and Powder

Food & Beverage

Confectionery

Dairy Products

Based on the End-User, the Global Pharmaceutical Gelatin Market is bifurcated into Protein Bars and Powder, Food & Beverage, Confectionery, and Dairy Products. The food and beverage segment currently leads the pharmaceutical gelatin market, thanks to its extensive applications and well-established consumer base. Gelatin's versatility in various food products, including confectioneries, dairy items, and desserts, solidifies its dominant position in this sector.

Pharmaceutical Gelatin Market, By Geography

North America

Europe

Asia Pacific

Rest of the world

Based on Geography, the Global Pharmaceutical Gelatin Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America substantially dominates the global pharmaceutical gelatin market and is expected to maintain its dominance throughout the forecast period driven by a combination of well-established pharmaceutical industries, robust research and development (R&D) activities, and a growing demand for pharmaceutical products. As the largest market for pharmaceutical gelatin in North America, the United States benefits from a mature pharmaceutical industry and significant investments in R&D.

Key Players

The "Global Pharmaceutical Gelatin Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Nitta Gelatin, PB Leiner GmbH, Tessenderlo Group, Weishardt Holding GmbH & Co. KG, Gelita AG, LAPI Gelatine, S.p.A., NiOx Gelatin, Croda International Plc, Eastman Chemical Company, Rousselot (ADM), I gelatine SA, Gelnex Pharmaceuticals, Bio-Gelatin GmbH, Gelatin Kelco Co.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Pharmaceutical Gelatin Market Key Developments

• In 2022, in response to the food industry's need to meet European Union food standards, Lonza enhanced their Capsugel contribution with a white hard gelatin capsule that is titanium dioxide-free.
• In May 2021, Darling Ingredients Inc. announced the launch of X-Pure GelDAT Gelatin Desaminotyrosine for biomedical applications under the Rousselot brand, expanding its pure pharmaceutical-grade modified gelatin portfolio.
• In July 2022, Gelita established a biotech hub to develop proteins for pharmaceutical and medical applications, cosmetics, and nutrition.
• In May 2022, Capsugel expanded its titanium dioxide-free capsule line, adding white firm gelatin capsules that are free of titanium dioxide (TiO2). The novel titanium dioxide-free capsule is based on crystalline salts and delivers similar masking and whitening properties as titanium dioxide capsules. The product provides excellent light shielding and opacity.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Pharmaceutical Gelatin Market, By Type

• Type A Gelatin
• Type B Gelatin

5. Pharmaceutical Gelatin Market, By Application

• Capsules and Softgel Capsules
• Coatings
• Parenteral Formulations
• Other Applications

6. Pharmaceutical Gelatin Market, By Source

• Bovine Gelatin
• Porcine Gelatin
• Other Sources

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Nitta Gelatin
• PB Leiner GmbH
• Tessenderlo Group
• Weishardt Holding GmbH & Co. KG
• Gelita AG
• LAPI Gelatine S.p.A.
• NiOx Gelatin
• Croda International Plc
• Eastman Chemical Company
• Rousselot (ADM)
• I gelatina SA
• Gelnex Pharmaceuticals
• Bio-Gelatin GmbH
• Gelatin Kelco Co.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities